Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Ensure quality: Medical channels often provide access to higher-quality peptides than research chemical markets
We source from reputable suppliers to ensure quality and authenticity
62 H 98 N 16 O 22 1419.55 g/mol 212 H 350 N 56 O 78 S 4963 g/mol Wolverine Blend Mechanism of Action BPC-157 drives angiogenic and growth-factor signaling, including VEGF/VEGFR2 engagement, FAK-paxillin and Rho-GTPase activation in fibroblast cultures, and nitric-oxide pathway modulation via L-NAME-sensitive, L-arginine-rescuable routes
Lyophilised IGF-1 LR3 maintains stability for 6-12 months when stored at standard refrigeration temperature
While most recovery agents focus on just one system like inflammation, joint lubrication, or protein synthesisBPC-157 works on multiple levels , improving tissue remodeling, vascular support, pain reduction, and even neurological repair
The conditions that most commonly support eligibility include: Obesity (BMI 30, or 27 with at least one comorbidity such as hypertension, sleep apnea, or cardiovascular disease) Type 2 diabetes or prediabetes Insulin resistance with clinical documentation Metabolic syndrome (clinically diagnosed) Polycystic Metabolic Ovarian Syndrome (PMOS) and related hormonal disorders Non-alcoholic fatty liver disease (NAFLD/MASLD) Perimenopause-related metabolic dysfunction with documented hormonal changes GLP-1 receptor agonists including semaglutide, tirzepatide, and retatrutide are the most commonly used peptides in metabolic care today
US$ 23.02
US$ 23.57
US$ 29.66
